Navigation Links
Anesiva Announces Pivotal Phase 3 Trial of Zingo(TM) Meets Primary Endpoint and Significantly Reduces Venous Access Pain in Adults
Date:10/16/2007

Company Plans to File Supplemental New Drug Application with FDA in First

Quarter 2008

SOUTH SAN FRANCISCO, Calif., Oct. 16 /PRNewswire-FirstCall/ -- Anesiva, Inc. (Nasdaq: ANSV) today announced positive top-line results from its pivotal Phase 3 trial. The multi-center, randomized, double-blind study with 699 adult patients met its primary endpoint, demonstrating less venous procedural pain in those treated with Zingo(TM) (lidocaine hydrochloride monohydrate) powder intradermal injection system compared to placebo (p= 0.003). Patients received Zingo or placebo one to three minutes prior to undergoing venous access procedures (IV insertions or blood draws). Zingo was found to be well tolerated in this patient population. Anesiva plans to file a supplemental new drug application (sNDA) with the U.S. Food and Drug Administration (FDA) in the first quarter of 2008 for the use of Zingo in adults.

"We've now shown that Zingo works in both the pediatric and adult populations. An expanded label from the FDA to include adults could greatly expand the market opportunity for us," said John P. McLaughlin, chief executive officer of Anesiva. "We have a world-class commercialization team that has significant efforts underway to prime the market for Zingo's introduction to pediatric hospitals in order to prepare for a strong launch and the development of a very successful business."

Zingo is already approved by the FDA to provide local analgesia prior to venipuncture or peripheral intravenous cannulation in children three to 18 years of age. Its onset of action is one to three minutes. Venous access procedures are among the most common procedures performed at a hospital, with more th
'/>"/>

SOURCE Anesiva, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Anesiva Announces Phase 2 Data Showing Substantial, Long-Term Pain Reductions with Adlea(TM) (formerly 4975) in Osteoarthritis of the Knee
2. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
3. Sygnis Pharma AG announces date for presentation of clinical results
4. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
7. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
8. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
9. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
10. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
11. Protox Announces Positive Clinical Data from Prostate Cancer Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... Utah , March 26, 2015  Flexpoint Sensor ... with new customers it has received and shipped during ... get a lot of interest in the sensors for ... these sensors or have had custom sensors built for ... LLC who received custom sensors for medical rehab; a ...
(Date:3/26/2015)... N.J. , March 26, 2015  Becton, Dickinson ... that it will commence offers to exchange all validly ... by CareFusion Corporation, a wholly owned subsidiary of BD, ... in the table below. A Registration Statement on Form ... the New Notes was filed with the Securities and ...
(Date:3/26/2015)... Ohio entrepreneur is introducing a product designed to give people ... start-up company known as SEED Protocol LLC, ... empower individuals to manage, review, and protect their healthcare files, ... The SEED Protocol – ... to protect their own health records by storing them in ...
Breaking Medicine Technology:Flexpoint Sensor Systems, Inc. Expands Customer Base with New Orders of Sensors 2Becton, Dickinson and Company to Commence Exchange Offers 2Becton, Dickinson and Company to Commence Exchange Offers 3Becton, Dickinson and Company to Commence Exchange Offers 4Becton, Dickinson and Company to Commence Exchange Offers 5Ohio Entrepreneur Develops Technology that Allows Patients Control Over Their Healthcare Records 2Ohio Entrepreneur Develops Technology that Allows Patients Control Over Their Healthcare Records 3Ohio Entrepreneur Develops Technology that Allows Patients Control Over Their Healthcare Records 4
... , WARSAW, Ind., Nov. 24 Zimmer Holdings, Inc. ... be participating in the 21st Annual Piper Jaffray Health Care Conference ... a.m. Eastern Time. , A live webcast of the ... http://investor.zimmer.com . The webcast will be archived for replay following ...
... 24 Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ), the leader ... overview at Piper Jaffray,s 21st Annual Health Care Conference on Tuesday, ... Palace Hotel. , A live audio webcast of the presentation will ... Web site, www.isispharm.com . A replay of the presentation ...
Cached Medicine Technology:
(Date:3/27/2015)... USA (PRWEB) March 27, 2015 According ... rates of newborns born with Neonatal Abstinence Syndrome (NAS) ... NAS will undergo the painful withdrawal process for a ... body tremors, excessive crying, diarrhea, and vomiting. The condition ... undergoing drug and alcohol addiction treatment (and employing medically ...
(Date:3/27/2015)... 2015 GrassrootsHealth, an international nonprofit public ... (POC) NOW! vitamin D demonstration project April 7 in ... Carolina (MUSC), and will soon follow with a second ... cost to a minimum of 500 pregnant women at ... two service areas. The project will include patient and ...
(Date:3/27/2015)... Operatic contenders and their avid audience will be in ... acclaimed baritone Sherrill Milnes will be overseeing the grand ... Merion in Evanston. The event is the culmination of ... from around the country. “This is a highly-anticipated yearly ... in the country,” said Margaret Gergen, executive director of ...
(Date:3/27/2015)... March 27, 2015 Approximately 300 ... Healthy Kids Coalition Lobby Day to lobby for ... Improvement Program (SHIP). Everlast Climbing was especially ... Bill SF343/HF498 which would strengthen physical education programs ... assessments and other measures to strengthen physical education ...
(Date:3/27/2015)... Airy Jeanine is a rising star. ... video for her debut song “Mama’s Girl”, launched on ... abstract styling effects, the thematic video for the rhythmic ... and assorted outlets. It will be integral in establishing, ... full-scale marketing strategy. The video promotion campaign spearheaded by ...
Breaking Medicine News(10 mins):Health News:In Florida Only 10% of Pregnant Mothers Are Referred to Drug Rehab Despite Testing Positive for Narcotics 2Health News:GrassrootsHealth Moves Vitamin D into Practice with Pregnant Women 2Health News:GrassrootsHealth Moves Vitamin D into Practice with Pregnant Women 3Health News:GrassrootsHealth Moves Vitamin D into Practice with Pregnant Women 4Health News:Opera Idol Competition At The Merion In Evanston 2Health News:Everlast Climbing Advocates to Strengthen Physical Education in Minnesota Schools 2Health News:Airy Jeanine Releases ‘’Mama’s Girl” Official Music Video 2
... Affirming its commitment,to preventing drunken driving tragedies ... has voted unanimously,to endorse the Ensign John R. ... HERO Campaign is a non-profit grassroots organization dedicated ... prevent drunken driving.,It was established by the family ...
... 12 A consumer,group today released a ... Jonathan,Gruber supporting mandatory purchase of private insurance ... Americans are "over-insured" and to,defend the affordability ... for Taxpayer and Consumer Rights, (FTCR),critique of ...
... mean yearly changes in formula , , TUESDAY, Feb. 12 (HealthDay ... to control noroviruses -- a common cause of stomach flu ... to be changed every year because the viruses evolve quickly ... suggests. , Noroviruses infect cells after attaching to histo-blood group ...
... PSI, a leading provider of child,support enforcement services ... contract with the Ohio Department of Job and ... services for the State --,a program the company ... run,for an initial period of one-and-a-half years with ...
... aimed at reducing cross contaminations including Norovirus and ... ... Fla., Feb. 12 Seal Shield LLC announced,that it has begun ... the SILVER SEAL(TM) Keyboard is the,world,s first computer keyboard to be ...
... The Generic Pharmaceutical,Association (GPhA) Board of Directors today named ... the election of William Marth,President and CEO of Teva ... Mr. Marth has 30 years of experience in ... is among the top 20,pharmaceutical companies in the world ...
Cached Medicine News:Health News:National Lt. Governors Association Endorses HERO Campaign; 1st National Association of State Elected Officials Supporting Grassroots Designated Driving Program 2Health News:Consumer Group Finds Use of Outdated Data and Other Major Flaws in Economist's Defense of Mandatory Purchase of Private Health Insurance 2Health News:Vaccine Could Cut Bouts With Stomach Flu 2Health News:Ohio Selects Policy Studies Inc. (PSI) to Continue Operating Its New Hire Reporting Program 2Health News:Seal Shield Ships New SILVER SEAL(TM) Washable, Antimicrobial Keyboard 2Health News:GPhA Announces 2008-2009 Executive Committee; Teva North America's Bill Marth Elected as Chairman of the Board 2
... OraQuick is an FDA ... venipuncture whole blood test used ... of HIV-1 infection. This CLIA ... presence of antibodies to HIV-1, ...
... QuickVue+ Infectious Mononucleosis test is ... antibodies in serum, plasma or whole ... utilizes an extract of bovine erythrocytes ... specificity than similar extracts prepared from ...
... the first available point-of-care diagnostic test that ... of influenza A and B. The test ... an enzyme that assists viral replication by ... infected cells. The ZstatFlu substrate is labeled ...
The NOW Flu A test is the most frequently adopted rapid flu test on the market today. Testing could not be easier and the results are available in 15 minutes. Now you can focus on the results and tre...
Medicine Products: